{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:31:46Z","timestamp":1779913906420,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00198-021-05950-2","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:52:58Z","timestamp":1619329978000},"page":"2111-2114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Asymptomatic elevated parathyroid hormone level due to immunoassay interference"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9397-1847","authenticated-orcid":false,"given":"M.B.","family":"Zanchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Giacoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-7145","authenticated-orcid":false,"given":"F.","family":"Jerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fradinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"5950_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cll.2004.01.003","volume":"1","author":"GG Klee","year":"2004","unstructured":"Klee GG (2004) Interferences in hormone immunoassays. Clin Lab Med 1:1\u201318","journal-title":"Clin Lab Med"},{"key":"5950_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","volume":"27","author":"N Bolstad","year":"2013","unstructured":"Bolstad N, Warren DJ, Nustad K (2013) Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab 27:647\u2013661","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5950_CR3","first-page":"105","volume":"24","author":"J Tate","year":"2004","unstructured":"Tate J, Ward G (2004) Interferences in immunoassay. Clin Biochem Rev 24:105\u2013120","journal-title":"Clin Biochem Rev"},{"key":"5950_CR4","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4158\/EP10235.CR","volume":"17","author":"O Levin","year":"2011","unstructured":"Levin O, Morris LF, Wah DT, Butch AW, Yeh MW (2011) Falsely elevated plasma parathyroid hormone level mimicking tertiary hyperparathyroidism. Endocr Pract 17:e8\u2013e11","journal-title":"Endocr Pract"},{"key":"5950_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ccr3.1664","volume":"6","author":"RHA van der Doelen","year":"2018","unstructured":"van der Doelen RHA, Nijhuis P, van der Velde R, Janssen MJW (2018) Normocalcemia but still elevated parathyroid hormone levels after parathyroidectomy. Clin Case Rep 6:1577\u20131581","journal-title":"Clin Case Rep"},{"key":"5950_CR6","first-page":"CC4","volume":"44","author":"P Prodan","year":"2016","unstructured":"Prodan P, Nandoshvilli E, Webster C, Shakher J (2016) Asymptomatic elevated PTH due to immunoassay interference resulting from Macro-PTH: a case report. Endocr Abstr 44:CC4","journal-title":"Endocr Abstr"},{"key":"5950_CR7","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1210\/jc.2019-01321","volume":"104","author":"M Laudes","year":"2019","unstructured":"Laudes M, Frohnert J, Ivanova K, Wandinger KP (2019) PTH immunoassay interference due to human anti-mouse antibodies in a subject with obesity with normal parathyroid function. J Clin Endocrinol Metab 104:5840\u20135842","journal-title":"J Clin Endocrinol Metab"},{"key":"5950_CR8","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1210\/jc.2014-4023","volume":"100","author":"O Gulbahar","year":"2015","unstructured":"Gulbahar O, Konca Degertekin C, Akturk M, Yalcin MM, Kalan I, Atikeler GF, Altinova AE, Yetkin I, Arslan M, Toruner F (2015) A case with immunoassay interferences in the measurement of multiple hormones. J Clin Endocrinol Metab 100:2147\u20132153","journal-title":"J Clin Endocrinol Metab"},{"key":"5950_CR9","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2003-030122","volume":"88","author":"CM Preissner","year":"2003","unstructured":"Preissner CM, O\u2019Kane DJ, Singh RJ, Morris JC, Grebe SK (2003) Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88:3069\u20133074","journal-title":"J Clin Endocrinol Metab"},{"key":"5950_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2007.08.019","volume":"387","author":"E Cavalier","year":"2008","unstructured":"Cavalier E, Carlisi A, Chapelle JP, Delanaye P (2008) False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin Chim Acta 387:150\u2013152","journal-title":"Clin Chim Acta"},{"key":"5950_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1365-2265.2006.02439.x","volume":"64","author":"AM Jones","year":"2006","unstructured":"Jones AM, Honour JW (2006) Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol 64:234\u2013244","journal-title":"Clin Endocrinol"},{"key":"5950_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cca.2016.10.016","volume":"467","author":"CM Sturgeon","year":"2017","unstructured":"Sturgeon CM, Sprague S, Almond A, Cavalier E, Fraser WD, Algeciras-Schimnich A, Singh R, Souberbielle JC, Vesper HW, IFCC Working Group for PTH (2017) Perspective and priorities for improvement of parathyroid hormone (PTH) measurement: a view from the IFCC Working Group for PTH. Clin Chim Acta 467:42\u201347","journal-title":"Clin Chim Acta"},{"key":"5950_CR13","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis [published correction appears in Osteoporos Int. 2015 Jul;26(7):2045-7]. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"5950_CR14","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3580\u20133594","journal-title":"J Clin Endocrinol Metab"},{"key":"5950_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"Bilezikian JP, Silverberg SJ (2010) Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 54:106\u2013109","journal-title":"Arq Bras Endocrinol Metabol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-05950-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T04:01:35Z","timestamp":1634097695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-05950-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5950"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-05950-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}